Roche eyes $1B-plus Tecentriq nod with small-cell lung cancer survival win

글 내용 전체보기

Express Scripts praises, then takes credit for Gilead’s authorized generics launches

글 내용 전체보기

AbbVie’s not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more

글 내용 전체보기

Arena 3 for 3 as Crohn’s drug meets proof-of-concept test

글 내용 전체보기

TG stock sinks after setback to blood cancer trial

글 내용 전체보기

Reata’s bardoxolone hits goals in phase 2 kidney disease trial

글 내용 전체보기

AGC adds mammalian capabilities to Japanese network

글 내용 전체보기

Scientists have discovered how to predict life of implants without animal testing

글 내용 전체보기

Study of protein ‘trafficker’ provides insight into autism and other brain disorders

글 내용 전체보기

First direct 3D maps of water during cell membrane fusion

글 내용 전체보기

Using viruses to fight resistant bacteria

글 내용 전체보기

Manganese plays a key role in bacterial infection

글 내용 전체보기

CPhI Pharma Award 2018 Finalists Revealed

글 내용 전체보기

Nothing Fishy Here: Amarin’s Fish Oil-Based Drug Dramatically Reduces Cardiovascular Risk

글 내용 전체보기

Some Cancer Cells Hide From Immunotherapy Treatments, Study Finds

글 내용 전체보기

FDA Action Alert: Merck, Insmed and Antares Pharma

글 내용 전체보기

AstraZeneca’s Diabetes Drug Farxiga Decreases Risk of Cardiovascular Disease

글 내용 전체보기

A Look at 7 Upcoming and Recently Announced Biotech IPOs

글 내용 전체보기

After Stumbling with Waylivra, Akcea Therapeutics’ Lipid Drug Shows Promise

글 내용 전체보기

BioSpace Movers and Shakers Sept. 24

글 내용 전체보기

Epizyme Announces Removal of FDA’s Partial Ban in Phase II Clinical Trials

글 내용 전체보기